ALPN

Alpine Immune Sciences, Inc. Common Stock

Delisted

ALPN was delisted on the 17th of May, 2024.

47 hedge funds and large institutions have $118M invested in Alpine Immune Sciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
8
Reduced
14
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PVI
51
Pura Vida Investments
New York
-$1.4M -131,981 Closed
Millennium Management
52
Millennium Management
New York
-$1.02M -96,017 Closed
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
-$633K -59,728 Closed
ECM
54
ExodusPoint Capital Management
New York
-$385K -36,359 Closed
MIM
55
Monashee Investment Management
Massachusetts
-$107K -29,652 Closed
HF
56
HRT Financial
New York
-$250K -23,593 Closed
Citadel Advisors
57
Citadel Advisors
Florida
-$234K -22,030 Closed
Qube Research & Technologies (QRT)
58
Qube Research & Technologies (QRT)
United Kingdom
-$154K -14,562 Closed
VCP
59
Vista Capital Partners
Oregon
-$152K -14,304 Closed
Goldman Sachs
60
Goldman Sachs
New York
-$112K -10,577 Closed
DWA
61
Dorsey Wright & Associates
California
-$35.8K -3,380 Closed
UBS Group
62
UBS Group
Switzerland
-$7K -689 Closed